Thyrocare Technologies Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20

Sources of funds

Owner's fund

Equity share capital

52.95

52.93

52.90

52.87

52.84

Share application money

-

4.51

3.43

2.93

3.72

Preference share capital

-

-

-

-

-

Reserves & surplus

460.86

463.60

464.37

389.66

321.67

Loan funds

Secured loans

19.77

-

-

-

-

Unsecured loans

-

-

-

-

-

Total

533.58

521.04

520.70

445.46

378.23

Uses of funds

Fixed assets

Gross block

284.67

264.69

236.95

191.48

165.76

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

125.38

108.02

87.56

72.33

54.20

Net block

159.29

156.67

149.39

119.15

111.56

Capital work-in-progress

0.76

0.82

2.15

8.28

3.87

Investments

291.46

273.94

259.39

273.81

239.37

Net current assets

Current assets, loans & advances

168.76

180.44

186.24

126.55

87.59

Less : current liabilities & provisions

86.69

90.83

76.47

82.33

64.16

Total net current assets

82.07

89.61

109.77

44.22

23.43

Miscellaneous expenses not written

-

-

-

-

-

Total

533.58

521.04

520.70

445.46

378.23

Notes:

Book value of unquoted investments

-

172.75

150.34

-

-

Market value of quoted investments

115.26

101.19

89.05

103.47

69.03

Contingent liabilities

299.65

-

-

129.05

234.11

Number of equity sharesoutstanding (Lacs)

529.53

529.30

529.03

528.74

528.36